4646-86-0 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-Methoxy dalbergione is used as a target for the development of diagnostic tools and therapeutic interventions aimed at reducing allergic reactions in individuals who are sensitized to it. This is particularly important for timberworkers who are at a higher risk of developing sensitization due to their occupational exposure.
Used in Research and Development:
(R)-4-Methoxy dalbergione is used as a key compound in the study of allergens and their effects on the human immune system. Research on (R)-4-METHOXYDALBERGIONE can contribute to a better understanding of the mechanisms behind allergic reactions and the development of new strategies for allergy prevention and treatment.
Used in Woodworking Industry:
(R)-4-Methoxy dalbergione is used as a reference compound in the development of safety measures and guidelines for the woodworking industry. By understanding the properties and effects of this allergen, industry professionals can implement appropriate precautions to minimize the risk of sensitization and allergic reactions among workers who handle Dalbergia nigra and Dalbergia latifolia Roxb. woods.
Check Digit Verification of cas no
The CAS Registry Mumber 4646-86-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,4 and 6 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 4646-86:
(6*4)+(5*6)+(4*4)+(3*6)+(2*8)+(1*6)=110
110 % 10 = 0
So 4646-86-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H14O3/c1-3-12(11-7-5-4-6-8-11)13-9-15(18)16(19-2)10-14(13)17/h3-10,12H,1H2,2H3
4646-86-0Relevant academic research and scientific papers
Stereoselective synthesis of (R)- and (S)-4-methoxydalbergione via asymmetric catalytic hydrogenation
Bissel, Philippe,Nazih, Abdesslame,Sablong, Rafael,Lepoittevin, Jean-Pierre
, p. 1283 - 1285 (2008/02/09)
(Matrix presented) (R)-(+)-and (S)-(-)-4-methoxydalbergione were synthesized in seven steps with an enantiomeric excess of up to 95% using an asymmetric catalytic hydrogenation step with [Rh((S,S)-bdpp)(NBD)]CIO4 or [Rh((R,R)-bdpp)(NBD)]CIOsub
